Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Minority Interest (2016 - 2021)

Historic Minority Interest for Cross Country Healthcare (CCRN) over the last 8 years, with Q2 2021 value amounting to $534000.0.

  • Cross Country Healthcare's Minority Interest rose 2505.85% to $534000.0 in Q2 2021 from the same period last year, while for Jun 2021 it was $534000.0, marking a year-over-year increase of 2505.85%. This contributed to the annual value of $534000.0 for FY2020, which is 3847.93% down from last year.
  • Cross Country Healthcare's Minority Interest amounted to $534000.0 in Q2 2021, which was up 2505.85% from $534000.0 recorded in Q1 2021.
  • In the past 5 years, Cross Country Healthcare's Minority Interest ranged from a high of $868000.0 in Q4 2019 and a low of $427000.0 during Q2 2020
  • In the last 5 years, Cross Country Healthcare's Minority Interest had a median value of $637500.0 in 2017 and averaged $629777.8.
  • In the last 5 years, Cross Country Healthcare's Minority Interest skyrocketed by 4765.96% in 2017 and then plummeted by 4126.55% in 2020.
  • Quarter analysis of 5 years shows Cross Country Healthcare's Minority Interest stood at $630000.0 in 2017, then rose by 6.35% to $670000.0 in 2018, then increased by 29.55% to $868000.0 in 2019, then crashed by 38.48% to $534000.0 in 2020, then changed by 0.0% to $534000.0 in 2021.
  • Its Minority Interest stands at $534000.0 for Q2 2021, versus $534000.0 for Q1 2021 and $534000.0 for Q4 2020.